Healthcare -
Biotechnology - NASDAQ - US
$ 9.02
2.85 %
$ 446 M
Market Cap
-2.45
P/E
KALV - SHORT-TERM DEBT
Short-term Debt KALV - KalVista Pharmaceuticals, Inc.
1.3 M
LAST VALUE
15.44%
2 YEAR CAGR
88.99%
5 YEAR CAGR
-8.20%
10 YEAR CAGR